ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,673Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 393

$521K Total Retail Price of All Prescriptions

Rank: 55 out of 393

1,022 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,022 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 1,022 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,535 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 808 755 1 1
LISINOPRIL 763 739 2 2
LEVOTHYROXINE SODIUM 736 662 3 3
OMEPRAZOLE 708 644 4 6
AMLODIPINE BESYLATE 493 468 5 4
HYDROCHLOROTHIAZIDE 341 321 6 10
ATENOLOL 339 326 7 13
HYDROCODONE-ACETAMINOPHEN 295 256 S3 8 5
METFORMIN HCL 287 254 9 7
METOPROLOL SUCCINATE 275 275 10 22
PRAVASTATIN SODIUM 268 262 11 18
METOPROLOL TARTRATE 258 250 12 9
ALENDRONATE SODIUM 244 244 13 16
LOVASTATIN 238 217 14 14
LOSARTAN POTASSIUM 235 218 15 12
ZOLPIDEM TARTRATE 218 196 16 11
FUROSEMIDE 213 191 17 8
WARFARIN SODIUM 197 192 18 17
GABAPENTIN 178 161 19 15
TRIAMTERENE-HCTZ 161 145 20 49
CARVEDILOL 150 132 21 21
TRAMADOL HCL 133 117 22 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 114 23 24
PAROXETINE HCL 131 131 23 61
GLYBURIDE 129 126 R 25 46
VENTOLIN HFA 127 115 26 42
GEMFIBROZIL 124 124 27 62
TERAZOSIN HCL 120 109 28 38
SERTRALINE HCL 116 89 29 28
PLAVIX 107 102 30 51
FLUOXETINE HCL 101 70 31 37
FLUTICASONE PROPIONATE 98 95 32 27
RANITIDINE HCL 97 85 33 29
SPIRIVA 96 96 34 41
CITALOPRAM HBR 93 82 35 23
GLIMEPIRIDE 90 86 36 39
BENAZEPRIL HCL 84 77 37 40
CLOPIDOGREL 79 72 38 33
BACLOFEN 79 64 38 79
IBUPROFEN 78 67 40 55
POTASSIUM CHLORIDE 75 72 41 20
LANTUS SOLOSTAR 74 68 42 74
BENICAR 73 61 43 118
FENOFIBRATE 72 61 44 43
METFORMIN HCL ER 69 63 45 63
CLONIDINE HCL 67 64 46 50
GLIPIZIDE ER 67 67 46 76
ALLOPURINOL 66 59 48 26
SYMBICORT 61 61 49 96
FINASTERIDE 59 59 50 60
ESTRADIOL 59 58 R 50 93
ISOSORBIDE MONONITRATE ER 58 52 52 67
HYDRALAZINE HCL 57 57 53 64
DIGOXIN 57 57 53 66
VERAPAMIL ER 54 54 55 86
EVISTA 53 47 56 98
KLOR-CON M20 52 45 57 137
OXYBUTYNIN CHLORIDE ER 52 51 57 122
CIPROFLOXACIN HCL 51 46 59 57
GLIPIZIDE 50 44 60 32
KLOR-CON 10 50 50 60 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.